Clinical experience of tabelecleucel in patients with EBV plus primary (PID) or acquired immunodeficiency (AID) associated lymphoproliferative disease

Please use this identifier to cite or link to this item: http://scholars.ntou.edu.tw/handle/123456789/1328

Title:	Clinical experience of tabelecleucel in patients with EBV plus primary (PID) or acquired immunodeficiency (AID) associated lymphoproliferative disease
Authors:	Nikiforow, S. Baiocchi, R. Nasta, S. Weng, W. Loeb, D. Mahadeo, K. M. Whangbo, J. Phuong, P. Navarro, W. Gamelin, L. Sun, Y. Guzman-Becerra, N. Prockop, S.
Issue Date:	Sep-2020
Journal Volume:	31
Source:	Annals of Oncology
URI:	http://scholars.ntou.edu.tw/handle/123456789/1328
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2020.08.1171
Appears in Collections:	河海工程學系

Show full item record

Last Week
2

Last month
0

checked on Oct 13, 2022

Check

DSpace CRIS